ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smythe, W. R.
Right arrow Articles by Albelda, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smythe, W. R.
Right arrow Articles by Albelda, S. M.

The Annals of Thoracic Surgery, Vol 57, 1395-1401, Copyright © 1994 by The Society of Thoracic Surgeons

ARTICLES

Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma

WR Smythe, LR Kaiser, HC Hwang, KM Amin, JM Pilewski, SJ Eck, JM Wilson and SM Albelda
Department of Surgery, University of Pennsylvania Medical Center, Philadelphia.

Malignant mesothelioma remains a frustrating clinical problem with uniformly poor responses to current therapeutic regimens. However, the localized nature of the disease, the potential accessibility of the tumor, and the relative lack of distant metastases make it a particularly attractive candidate for somatic gene therapy. The purpose of this study was to evaluate the ability of an adenoviral vector system to transfer genetic material to human mesothelioma cells in vitro and in vivo. Using a replication-deficient recombinant adenovirus carrying the Escherichia coli lacZ marker gene, we found that human mesothelioma cell lines were susceptible to adenovirus infection. Furthermore, surprisingly effective gene transfer was accomplished within tumor implants of human mesothelioma growing within the peritoneal cavity of immunodeficient mice after intraperitoneal administration of virus. These studies demonstrate that adenoviral vectors hold promise as vehicles to deliver gene therapy in human malignant mesothelioma.


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
A. Sartore-Bianchi, F. Gasparri, A. Galvani, L. Nici, J. W. Darnowski, D. Barbone, D. A. Fennell, G. Gaudino, C. Porta, and L. Mutti
Bortezomib Inhibits Nuclear Factor-{kappa}B Dependent Survival and Has Potent In vivo Activity in Mesothelioma
Clin. Cancer Res., October 1, 2007; 13(19): 5942 - 5951.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. H. Sterman, A. Recio, R. G. Carroll, C. T. Gillespie, A. Haas, A. Vachani, V. Kapoor, J. Sun, R. Hodinka, J. L. Brown, et al.
A Phase I Clinical Trial of Single-Dose Intrapleural IFN-{beta} Gene Transfer for Malignant Pleural Mesothelioma and Metastatic Pleural Effusions: High Rate of Antitumor Immune Responses
Clin. Cancer Res., August 1, 2007; 13(15): 4456 - 4466.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. P. J. J. Hegmans, A. Hemmes, J. G. Aerts, H. C. Hoogsteden, and B. N. Lambrecht
Immunotherapy of Murine Malignant Mesothelioma Using Tumor Lysate-pulsed Dendritic Cells
Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1168 - 1177.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Sako, J. Kitayama, H. Koyama, H. Ueno, H. Uchida, H. Hamada, and H. Nagawa
Transduction of Soluble Flt-1 Gene to Peritoneal Mesothelial Cells Can Effectively Suppress Peritoneal Metastasis of Gastric Cancer
Cancer Res., May 15, 2004; 64(10): 3624 - 3628.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. D. Martin-Martinez, M. Stoenoiu, C. Verkaeren, O. Devuyst, and C. Delporte
Recombinant adenovirus administration in rat peritoneum: endothelial expression and safety concerns
Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1293 - 1297.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
R. J. Kruklitis, S. Singhal, P. Delong, V. Kapoor, D. H. Sterman, L. R. Kaiser, and S. M. Albelda
Immuno-gene therapy with interferon-{beta} before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma
J. Thorac. Cardiovasc. Surg., January 1, 2004; 127(1): 123 - 130.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. J. Devin, Y.C. G. Lee, R. W. Light, and K. B. Lane
Pleural Space as a Site of Ectopic Gene Delivery: Transfection of Pleural Mesothelial Cells With Systemic Distribution of Gene Product
Chest, January 1, 2003; 123(1): 202 - 208.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Tsukuda, R. Wiewrodt, K. Molnar-Kimber, V. P. Jovanovic, and K. M. Amin
An E2F-responsive Replication-selective Adenovirus Targeted to the Defective Cell Cycle in Cancer Cells: Potent Antitumoral Efficacy but No Toxicity to Normal Cell
Cancer Res., June 1, 2002; 62(12): 3438 - 3447.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
W. R. Smythe
Gene therapy for thoracic disease: practice, promise, and pragmatism
Ann. Thorac. Surg., March 1, 2002; 73(3): 704 - 706.
[Full Text] [PDF]

Home page
 BloodHome page
R. Wiewrodt, A. P. Thomas, L. Cipelletti, M. Christofidou-Solomidou, D. A. Weitz, S. I. Feinstein, D. Schaffer, S. M. Albelda, M. Koval, and V. R. Muzykantov
Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells
Blood, February 1, 2002; 99(3): 912 - 922.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Odaka, D. H. Sterman, R. Wiewrodt, Y. Zhang, M. Kiefer, K. M. Amin, G.-P. Gao, J. M. Wilson, J. Barsoum, L. R. Kaiser, et al.
Eradication of Intraperitoneal and Distant Tumor by Adenovirus-mediated Interferon-{beta} Gene Therapy Is Attributable to Induction of Systemic Immunity
Cancer Res., August 1, 2001; 61(16): 6201 - 6212.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. H. Sterman, L. R. Kaiser, and S. M. Albelda
Advances in the Treatment of Malignant Pleural Mesothelioma
Chest, August 1, 1999; 116(2): 504 - 520.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. E. Rogers, S. F. McLean, R. L. Kirkman, D. Della Manna, S. J. Bright, C. C. Olsen, A. D. Myracle, M. S. Mayo, D. T. Curiel, and D. J. Buchsbaum
In Vivo Localization of [111In]-DTPA-D-Phe -Octreotide to Human Ovarian Tumor Xenografts Induced to Express the Somatostatin Receptor Subtype 2 Using an Adenoviral Vector
Clin. Cancer Res., February 1, 1999; 5(2): 383 - 393.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
P. Schwarzenberger, D. Lei, S. M. Freeman, P. Ye, A. Weinacker, C. Theodossiou, W. Summer, and J. K. Kolls
Antitumor Activity with the HSV-tk-gene-modified Cell Line PA-1-STK in Malignant Mesothelioma
Am. J. Respir. Cell Mol. Biol., August 1, 1998; 19(2): 333 - 337.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. Lee, H. Laks, D. C. Drinkwater, A. Blitz, L. Lam, Y. Shiraishi, P. Chang, T. A. Drake, and A. Ardehali
CARDIAC GENE TRANSFER BY INTRACORONARY INFUSION OF ADENOVIRUS VECTOR--MEDIATED REPORTER GENE IN THE TRANSPLANTED MOUSE HEART
J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 246 - 252.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
J. C. Kucharczuk, A. A. Elshami, H. B. Zhang, W. R. Smythe, H. C. Hwang, J. S. Tomlinson, K. M. Amin, L. A. Litzky, S. M. Albelda, and L. R. Kaiser
Pleural-Based Mesothelioma in Immune Competent Rats: A Model to Study Adenoviral Gene Transfer
Ann. Thorac. Surg., September 1, 1995; 60(3): 593 - 597.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 by The Society of Thoracic Surgeons.